Results 11 to 20 of about 1,825 (127)

Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders [PDF]

open access: yesInternational Journal of Molecular Sciences, 2023
Ubiquitination and deubiquitination are reversible processes that modify the characteristics of target proteins, including stability, intracellular localization, and enzymatic activity. Ubiquitin-specific proteases (USPs) constitute the largest deubiquitinating enzyme family.
Hiroshi Kitamura, Kitamura Hiroshi
exaly   +4 more sources

Correction: Ubiquitin-specific proteases (USPs) in leukemia: a systematic review [PDF]

open access: yesBMC Cancer
Alireza Zangooie   +9 more
doaj   +3 more sources

Literature review: nuclear factor kappa B (NF-κB) regulation in human cancers mediated by ubiquitin-specific proteases (USPs) [PDF]

open access: yesAnnals of Translational Medicine
The nuclear factor kappa B (NF-κB) consists of a group of transcription factors of which its dysregulation is responsible for diseases such as inflammation and cancer. Ubiquitin-specific proteases (USPs) are the most prominent group among the deubiquitinases (DUBs).
Shen K, Zhang Q.
exaly   +4 more sources

USP52 promotes clear cell renal carcinoma progression by deubiquitinating and stabilizing CORO6 [PDF]

open access: yesTranslational Oncology
Clear cell renal carcinoma (ccRCC) is the most common type of kidney cancer. CORO6 functions as an oncogene in various malignancies, including ccRCC, but the mechanisms regulating its expression, particularly at the post-translational level, remain ...
Xinjun Wang   +9 more
doaj   +2 more sources

Roles of ubiquitin-specific proteases in inflammatory diseases

open access: yesFrontiers in Immunology
Ubiquitin-specific proteases (USPs), as one of the deubiquitinating enzymes (DUBs) families, regulate the fate of proteins and signaling pathway transduction by removing ubiquitin chains from the target proteins.
Rui Chen   +18 more
doaj   +3 more sources

Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy

open access: yesFrontiers in Pharmacology, 2018
Dysfunction or dysregulation of the ubiquitin proteasome system (UPS) is closely related to tumorigenesis and the development of multiple cancers. Targeting the UPS provides a new anticancer therapeutic strategy, but clinically available UPS-targeted ...
Tao Yuan   +6 more
doaj   +3 more sources

Unravelling the role of ubiquitin-specific proteases in breast carcinoma: insights into tumour progression and immune microenvironment modulation [PDF]

open access: yesWorld Journal of Surgical Oncology
Breast cancer is a prevalent malignancy worldwide, and its treatment has increasingly shifted towards precision medicine, with immunotherapy emerging as a key therapeutic strategy.
Huiyuan Yang   +7 more
doaj   +2 more sources

Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects [PDF]

open access: yesBiomolecules
Cancer management has traditionally depended on chemotherapy as the mainstay of treatment; however, recent advancements in targeted therapies and immunotherapies have offered new options.
Mohamad Bakkar   +9 more
doaj   +2 more sources

Ubiquitin-specific protease 34 serves as a novel prognostic biomarker through correlating with immune responses and cell proliferation in acute myeloid leukemia [PDF]

open access: yesDiscover Oncology
Background Emerging evidence showed that ubiquitin-specific proteases (USPs) are promising therapeutic targets for hematopoietic malignancies. The roles of USP34 on acute myeloid leukemia (AML) pathogenesis remain completely unknown.
Zhihui Li, Cuijuan Shi
doaj   +2 more sources

USPs and non-coding RNAs: Unraveling their interplay within tumor microenvironment for targeted cancer therapy

open access: yesPharmacological Research
Cancer represents a significant global health threat, with the World Health Organization reporting millions of new cases annually. Dysregulation in cellular homestasis leads to the aggressive and heterogeneous nature of cancers.
Yongqing Xu   +7 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy